On January 31, 2024 ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, reported that management will participate in the following investor conferences in February (Press release, ORIC Pharmaceuticals, JAN 31, 2024, View Source [SID1234639747]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

6th Annual Guggenheim Biotechnology Conference – Participating in a fireside chat on Wednesday, February 7, 2024, at 10:00 a.m. ET.

Oppenheimer 34th Annual Healthcare Life Sciences Conference – Participating in a virtual fireside chat on Wednesday, February 14, 2024, at 12:00 p.m. ET.

Webcasts of the discussions will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 30 days following each event.